U.S. FDA Triples Estimate On Deaths Following Allergic Reaction To Blood Thinner Heparin
This article was originally published in PharmAsia News
Executive Summary
BEIJING - U.S. FDA last week issued a sharply higher estimate on the number of deaths that have occurred in patients who suffered allergic reactions to the blood thinner heparin
You may also be interested in...
U.S. FDA Set To Strengthen Inspections Of Chinese Drugmakers, Search For Adulterants In Aftermath Of Heparin Deaths – CDER Official
BEIJING - As U.S. FDA leaders select inspectors to deploy across three new offices being set up in China, the organization is also preparing to ramp up the number of inspections and the level of scrutiny of Chinese drugmakers that export to the U.S
FDA Set To Strengthen Inspections Of Chinese Drugmakers In Aftermath Of Heparin Deaths – CDER Official
CDER's Buhay notes "there will be many multiples" of the current number of inspections following the opening of three new offices in China.
FDA Set To Strengthen Inspections Of Chinese Drugmakers In Aftermath Of Heparin Deaths – CDER Official
CDER's Buhay notes "there will be many multiples" of the current number of inspections following the opening of three new offices in China.
Need a specific report? 1000+ reports available
Buy Reports